Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
09/2003
09/17/2003EP1133471B1 Hydrazine derivatives
09/17/2003EP1123296B1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION
09/17/2003EP1105132B1 The use of r(+)-g(a)-(2,3-dimethoxyphenyl)-1- 2-(4-fluorophenyl)ethyl]-4-piperidinemethanol for the treatment of obstructive sleep apnea
09/17/2003EP1095021B1 Quinoline derivatives
09/17/2003EP0996446B1 Novel substituted imidazole compounds
09/17/2003EP0941099B1 Treatment of bronchitis with diuridine tetraphosphate
09/17/2003EP0910566B1 Heterocyclic compounds and their preparation and use
09/17/2003EP0769940B1 INDENE sPLA2 INHIBITORS
09/17/2003EP0768089B1 Hot water extract of Cordyceps sinensis
09/17/2003EP0724647A4 Nucleic acid ligands and improved methods for producing the same
09/17/2003CN1443241A Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, proteins encoded, and uses thereof
09/17/2003CN1443199A Antibodies to human MCP-1
09/17/2003CN1443187A Fused cyclic compounds as modulators of nuclear hormone receptor function
09/17/2003CN1443184A 嘧啶衍生物 Pyrimidine derivatives
09/17/2003CN1443173A Substituted imidazoles as TAFI a inhibitors
09/17/2003CN1443170A Capsaicin receptor ligands
09/17/2003CN1443165A Cyclopentanoindoles, compositions containing such compounds and methods of treatment
09/17/2003CN1443164A Pyrrolidine derivatives as metalloprotease inhibitors
09/17/2003CN1443163A Pyrrolidine-2-carboxylic acid hydrozide derivatives for use as metalloprotease inhibitors
09/17/2003CN1443075A Compositions and methods for treatment of candidiasis
09/17/2003CN1443065A Pharmaceutical composition improved in peroral absorbability
09/17/2003CN1442166A Syrup for panting calm and relieving cough
09/17/2003CN1442155A Lulusu synthetic medicinal liquid
09/17/2003CN1442139A Medicinal composition for treating inflammation
09/17/2003CN1121441C Method of detecting lung disease
09/17/2003CN1121398C Alicyclic acylated heterocyclic derivatives
09/17/2003CN1121234C Antiphlogistic cough relieving medicine
09/17/2003CN1121229C Medicinal bag for preventing cold
09/16/2003US6620919 Lipoxin compounds and their use in treating cell proliferative disorders
09/16/2003US6620915 Monoclonal antibodies specific for integrin α-d subunit
09/16/2003US6620840 Derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
09/16/2003US6620832 Substituted ureas
09/16/2003US6620811 Isonicotin- and nicotinamide derivatives of benzothiazoles
09/16/2003CA2249009C Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors
09/16/2003CA2238875C Tri-aryl ethane derivatives as pde iv inhibitors
09/16/2003CA2107219C S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof
09/16/2003CA2086206C Hypocariogenic hydrogenated starch hydrolysate, process for preparing it and the application of this hydrolysate
09/16/2003CA2047857C (quinolin-2-ylmethoxy)heterotetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes
09/15/2003CA2421490A1 Medicament against thrombotic diseases
09/12/2003WO2003074654A2 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina)
09/12/2003WO2003074530A1 Bicyclic pyridine and pyrimidine p38 kinase inhibitors
09/12/2003WO2003074483A1 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
09/12/2003WO2003074469A1 Novel cinnamate salts, method for production and use thereof as medicaments
09/12/2003WO2003074055A1 Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist
09/12/2003WO2003074036A1 Novel formulation
09/12/2003WO2003074025A2 Pressurised metered dose inhalers containing solutions of beta-2 agonists
09/12/2003WO2003074008A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003WO2003073990A2 Treatment for asthma or allergies
09/12/2003WO2003073986A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003WO2003051828A3 (20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
09/12/2003WO2003051333B1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
09/12/2003WO2003034987A3 Androgen receptor modulators and methods of use thereof
09/12/2003WO2003033014A3 Novel use of pulmonary surfactant
09/12/2003WO2003002522A3 Peptide deformylase inhibitors
09/12/2003WO2002098874A3 Inhalation capsules
09/12/2003WO2002080979A3 Conjugate of hydroxyalkyl starch and an active agent
09/12/2003WO2002058695A9 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/12/2003WO2002040486A3 METHODS OF TREATING p38 KINASE-ASSOCIATED CONDITIONS AND PYRROLOTRIAZINE COMPOUNDS USEFUL AS KINASE INHIBITORS
09/12/2003WO2002032961A8 Novel polypeptides and nucleic acids encoding same
09/12/2003WO2002028424A9 Kyberdrug as autovaccines with immune-regulating effects
09/12/2003WO2001095785A3 Modulation of immune response and methods based thereon
09/12/2003CA2478612A1 Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist
09/12/2003CA2477721A1 Bicyclic pyridine and pyrimidine p38 kinase inhibitors
09/12/2003CA2477715A1 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient
09/12/2003CA2477449A1 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003CA2477423A1 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003CA2477400A1 Treatment for asthma or allergies
09/12/2003CA2455447A1 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina)
09/11/2003WO2003074024A1 Formoterol superfine formulation
09/11/2003US20030172389 Surfactant protein D for the prevention and diagnosis of pulmonary emphysema
09/11/2003US20030171584 6-Substituted pyrido-pyrimidines
09/11/2003US20030171564 Novel argS
09/11/2003US20030171541 Selective binding agents, vectors, host cells, and methods for producing GPCR polypeptides; diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with GPCR polypeptides
09/11/2003US20030171415 Strokes; cardiovascular disorders; mixture of melmisartan and ramipril
09/11/2003US20030171404 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors
09/11/2003US20030171402 Method of treating neutrophil-related diseases with topical anesthetics
09/11/2003US20030171400 Rheumatic diseases; osteoporosis; multiple sclerosis; autoimmune disease; joint replacements
09/11/2003US20030171392 Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof
09/11/2003US20030171389 Anticancer agents; bone disorders; antiarthritic agents
09/11/2003US20030171384 8-Quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors
09/11/2003US20030171362 Amino-tetralin derivatives as muscarinic receptor antagonists
09/11/2003US20030171361 Treatment of impotence, sexual dysfunction in female, stable, unstable and variant angina, hypertension, pulmonary hypertension, congestive heart failure, atherosclerosis
09/11/2003US20030171357 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
09/11/2003US20030171354 Indole derivatives
09/11/2003US20030171352 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators
09/11/2003US20030171337 Useful in the treatment and prophylaxis of inflammatory conditions or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammalian animal including human and primate, non-mammalian animal and
09/11/2003US20030171324 Reagents which bind to human DESC1-like serine protease gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to cancer, chronic obstructive pulmonary disease (COPD),
09/11/2003US20030171309 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
09/11/2003US20030171267 Albumin fusion proteins
09/11/2003US20030170859 Gene expression inhibition; for treatment of inflammatory, neurological, cardiovascular, and neoplastic tisssue growth disorders
09/11/2003US20030170648 Autoimmune diseases; inflammatory bowel disease; multiple sclerosis; rheumatic diseases; modulate gene expression
09/11/2003US20030170322 Throat care agents
09/11/2003US20030170304 Delivers an active ingredient in a pulsed or bimodal manner.
09/11/2003US20030170233 Treating Autoimmune Diseases with Humanized Anti-CD40L Antibody
09/11/2003US20030170212 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
09/11/2003US20030167924 Portable oxygen concentrator
09/10/2003EP1342723A1 Indole derivatives and use thereof in medicines
09/10/2003EP1342721A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
09/10/2003EP1342469A2 Stable glass state powder formulations
09/10/2003EP1341921A2 Hydrolases
1 ... 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 ... 878